Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
PHASE1
The purpose of this study is to evaluate the safety and immunogenicity of o...
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine NaΓ―ve Individuals
PHASE1
The purpose of this study is to evaluate the immunogenicity and safety of i...
Status
Completed
Location
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
PHASE1
A phase I prospective, randomized study in healthy adult subjects at a sing...
Status
Completed
Location
University of Rochester Medical Center - Vaccine Research Unit
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
PHASE1
The purpose of this study is to assess priming with antigenically mismatche...
Status
Completed
Location
University of Rochester Medical Center Vaccine Research Unit (Outpatient)